Navigation Links
Scientists Make Clones of Mice Dead 16 Years
Date:11/3/2008

Feat represents another advance in stem cell research, experts say

MONDAY, Nov. 3 (HealthDay News) -- Japanese scientists have succeeded in creating cloned mice from mouse bodies that had been frozen for up to 16 years.

While the feat may raise the specter of resurrecting lost species a la Jurassic Park, study senior author Teruhiko Wakayama said recreating woolly mammoths was "probably impossible."

He and his co-authors did acknowledge, however, the possibility of preserving endangered species and perhaps resurrecting other extinct species.

Other experts thought the implications of such technology could be more immediate -- and more human.

"Learning how to manipulate stem cells is an important enterprise, and scientists should be fully engaged in this. Whether we apply it toward bringing back dinosaurs or taking care of real needs on this planet is another question," said Richard Finnell, professor in the Center for Environmental and Genetic Medicine at the Texas A&M Health Science Center Institute of Biosciences and Technology.

"Stem cell biology offers tremendous upside, [but] the technology needs to be refined, and these scientists have come up with a way to manipulate these stem cells," Finnell continued. "Science is an interdisciplinary process. If we can grasp a technique that has been used for one approach, it really could be quite beneficial to how we deal with clinical problems today."

Scientists have cloned other species -- including celebrity sheep Dolly -- by using two live cells. Genetic material is taken from an unfertilized egg and then transferred to another live cell for "incubation," a process known as nuclear transfer.

Until now, researchers had believed that ice crystals formed in frozen cells would cause irreparable damage to the DNA, making cloning of long-dead animals impossible.

Wakayama, of the Laboratory for Genomic Reprogramming at the Center for Developmental Biology in Kobe, Japan, and his colleagues took brain tissue from a mouse strain frozen at minus 20 degrees Celsius for up to 16 years and transferred the nuclei (containing the genetic material) to empty egg cells.

These two-cell embryos were used to generate embryonic stem cell lines that resulted in 12 healthy cloned mice, which grew into normal adults.

The technique did not require nuclei from an intact donor cell. The cloning efficiency was about the same as using conventional cloning methods, the study authors stated.

The findings were published in the Nov. 3-7 issue of Proceedings of the National Academy of Sciences.

More information

The U.S. National Institutes of Health has more on stem cells.



SOURCES: Teruhiko Wakayama, Ph.D., Laboratory for Genomic Reprogramming, Center for Developmental Biology, Kobe, Japan; Richard Finnell, Ph.D., professor, Center for Environmental and Genetic Medicine, Texas A&M Health Science Center Institute of Biosciences and Technology, and director, Texas Institute for Genomic Medicine, both in Houston; Nov. 3-7, 2008, Proceedings of the National Academy of Sciences


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
2. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
3. Scientists Develop New Strategy to Fight Obesity
4. Scientists Spot 4 New Alzheimers Genes
5. Scientists Identify Brains Hate Circuit
6. Scientists identify new gene responsible for puberty disorders
7. Gladstone scientists identify role of fatty acids in Alzheimers disease
8. Scientists Hot on Trail of New Antibiotics
9. Scientists close in on method to fight deadly childhood cancer
10. NIH scientists discover crucial control in long-lasting immunity
11. New Site Launched for Families and Scientists to Discuss Stem Cell Research (US)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology: